Michael Fannon

1.6k total citations
22 papers, 1.3k citations indexed

About

Michael Fannon is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Michael Fannon has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Cell Biology and 5 papers in Cancer Research. Recurrent topics in Michael Fannon's work include Proteoglycans and glycosaminoglycans research (11 papers), Fibroblast Growth Factor Research (10 papers) and Angiogenesis and VEGF in Cancer (6 papers). Michael Fannon is often cited by papers focused on Proteoglycans and glycosaminoglycans research (11 papers), Fibroblast Growth Factor Research (10 papers) and Angiogenesis and VEGF in Cancer (6 papers). Michael Fannon collaborates with scholars based in United States, Germany and Canada. Michael Fannon's co-authors include Matthew A. Nugent, Judah Folkman, Kimberly E. Forsten, Arja Kaipainen, Catherine Butterfield, Steven Pirie‐Shepherd, O. Kisker, Robert J. D’Amato, Evelyn Flynn and Kimberly Forsten‐Williams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Michael Fannon

19 papers receiving 1.2k citations

Peers

Countries citing papers authored by Michael Fannon

Since Specialization

Citations

This map shows the geographic impact of Michael Fannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fannon more than expected).

Fields of papers citing papers by Michael Fannon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fannon. The network helps show where Michael Fannon may publish in the future.

Co-authorship network of co-authors of Michael Fannon

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Fannon. A scholar is included among the top collaborators of Michael Fannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Fannon. Michael Fannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of lymphatic malformations using primary cells and tissue transcriptomes 2019 ·Scandinavian Journal of Immunology ·Arja Kaipainen, (unknown), (unknown), Bing Zhao, Hainsworth Y. Shin, Andreas Stahl, Steven J. Fishman, John B. Mulliken, Judah Folkman, Sui Huang, Michael Fannon	5
2	Comparison of a high throughput day case atrial fibrillation ablation service in a local hospital with standard regional tertiary cardiac centre care 2018 ·EP Europace ·(unknown), (unknown), Alison Butler, (unknown), Michael Fannon, Malcolm Finlay, Ross J. Hunter, Richard J. Schilling	29
3	Fluid Pressure Is a Magnitude-Dependent Modulator of Early Endothelial Tubulogenic Activity: Implications Related to a Potential Tissue-Engineering Control Parameter 2012 ·Tissue Engineering Part A ·Hainsworth Y. Shin, (unknown), Michael Fannon	11
4	Facilitated diffusion of VEGF165 through descemet's membrane with sucrose octasulfate 2012 ·Journal of Cellular Physiology ·Michael Fannon, Kimberly Forsten‐Williams, Bing Zhao, (unknown), (unknown), Chia Lin Chu, (unknown), Jo Ann Buczek‐Thomas, Matthew A. Nugent	6
5	Parallel simulation of multiple proteins through a bioreactor coupled with biochemical reactions 2011 ·Changjiang Zhang, Kimberly Forsten‐Williams, Michael Fannon, (unknown), Jun Zhang	0
6	Vitamin D Binding Protein-Macrophage Activating Factor Directly Inhibits Proliferation, Migration, and uPAR Expression of Prostate Cancer Cells 2010 ·PLoS ONE ·(unknown), (unknown), Diane R. Bielenberg, Sami Dridi, Jason Wu, Weihua Jiang, Bin Huang, Steven Pirie‐Shepherd, Michael Fannon	53
7	Endothelial Cell Capture of Heparin-Binding Growth Factors under Flow 2010 ·PLoS Computational Biology ·Bing Zhao, Changjiang Zhang, Kimberly Forsten‐Williams, Jun Zhang, Michael Fannon	11
8	Coupling between heparan sulfate proteoglycans and FGF-2 receptors is key to FGF-2 capture under flow 2010 ·Changjiang Zhang, Kimberly Forsten‐Williams, (unknown), Michael Fannon, Jun Zhang	0
9	A Computational Model of FGF-2 Binding and HSPG Regulation Under Flow 2009 ·IEEE Transactions on Biomedical Engineering ·(unknown), Changjiang Zhang, Michael Fannon, Kimberly Forsten‐Williams, Jun Zhang	12
10	Simulation of FGF-2 Binding with Receptors on Cell Surface on the Wall in a Bioreactor System. 2008 ·Changjiang Zhang, (unknown), Kimberly Forsten‐Williams, Michael Fannon, Jun Zhang	0
11	Control of Growth Factor Networks by Heparan Sulfate Proteoglycans 2008 ·Annals of Biomedical Engineering ·Kimberly Forsten‐Williams, Chia Lin Chu, Michael Fannon, Jo Ann Buczek‐Thomas, Matthew A. Nugent	66
12	PPARα agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition 2008 ·Proceedings of the National Academy of Sciences ·Dipak Panigrahy, Arja Kaipainen, Sui Huang, Catherine Butterfield, Carmen M. Barnés, Michael Fannon, Andrea Laforme, Deviney M. Chaponis, Judah Folkman, Mark W. Kieran	227
13	Sucrose octasulfate regulates fibroblast growth factor‐2 binding, transport, and activity: Potential for regulation of tumor growth 2007 ·Journal of Cellular Physiology ·Michael Fannon, Kimberly Forsten‐Williams, Matthew A. Nugent, (unknown), Chia Lin Chu, (unknown), Dipak Panigrahy, Arja Kaipainen, Carmen Barnes, (unknown), Yuen Shing	8
14	Dose-dependent response of FGF-2 for lymphangiogenesis 2004 ·Proceedings of the National Academy of Sciences ·(unknown), Guillermo García‐Cardeña, Filip Farnebo, Michael Fannon, Emy J. Chen, Catherine Butterfield, Marsha A. Moses, Richard C. Mulligan, Judah Folkman, Arja Kaipainen	215
15	Vitamin D Binding Protein-Macrophage Activating Factor (DBP-maf) Inhibits Angiogenesis and Tumor Growth in Mice 2003 ·Neoplasia ·O. Kisker, Shinya Onizuka, Christian M. Becker, Michael Fannon, Evelyn Flynn, Robert J. D’Amato, Bruce R. Zetter, Judah Folkman, Rahul Ray, Narasimha Swamy, Steven Pirie‐Shepherd	100
16	Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. 2001 ·PubMed ·O. Kisker, C.-M. Becker, (unknown), Michael Fannon, Robert J. D’Amato, Evelyn Flynn, (unknown), B. Kim Lee Sim, (unknown), Steven Pirie‐Shepherd, Judah Folkman	217
17	Recovery of mouse endostatin produced by Pichia pastoris using expanded bed adsorption 2000 ·PubMed ·Loc Trinh, Santosh Noronha, Michael Fannon, Joseph Shiloach	18
18	Potential Mechanisms for the Regulation of Growth Factor Binding by Heparin 2000 ·Journal of Theoretical Biology ·Kimberly E. Forsten, Michael Fannon, Matthew A. Nugent	32
19	Potentiation and Inhibition of bFGF Binding by Heparin: A Model for Regulation of Cellular Response 2000 ·Biochemistry ·Michael Fannon, Kimberly E. Forsten, Matthew A. Nugent	130
20	Basic Fibroblast Growth Factor Binds Its Receptors, Is Internalized, and Stimulates DNA Synthesis in Balb/c3T3 Cells in the Absence of Heparan Sulfate 1996 ·Journal of Biological Chemistry ·Michael Fannon, Matthew A. Nugent	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact